A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of this Phase II trial is to compare the efficacy and safety of 6 months of
treatment with thymalfasin plus trans arterial chemoembolization (TACE) with TACE alone in
adult patients with non-surgical hepatocellular carcinoma (HCC).